977 |
Perspectives on the Evolution of IVUS into a Clinical Tool |
Gary S. Mintz |
Nov. 26. 09 |
976 |
Survival in patients with heart failure and preserved versus impaired left ventricular ejection fraction: an individual patient data meta-analysis: MAGGIC. |
|
Sep. 29. 09 |
975 |
Fractional flow reserve versus angiography for guiding PCI. |
|
Sep. 29. 09 |
974 |
Optimal revascularization strategy in patients with three-vessel disease and/or left main disease: The 2 year outcomes of the SYNTAX Trial. |
|
Sep. 29. 09 |
973 |
Clinical outcome after thrombectomy or standard angioplasty in patients with ST elevation myocardial infarction: individual patient-data pooled analysis of 11 randomized trials. ATTEMPT. |
|
Sep. 29. 09 |
972 |
Impact of bleeding types on mortality after PCI: Results from a patient-level pooled analysis of the REPLACE-2, ACUITY and HORIZONS trials. |
|
Sep. 29. 09 |
971 |
International impact of atherothrombotic vascular disease and events - 3-year data from the REACH Registry. |
|
Sep. 29. 09 |
970 |
Randomized evidence on Rosuvastatin for primary prevention in individuals 70 years of age or older. JUPITER. |
|
Sep. 29. 09 |
969 |
Effect of rosiglitazone on coronary events in the RECORD study. |
|
Sep. 29. 09 |
968 |
The risk of cardiovascular event for patients treated with clopidogrel or prasugrel in combination with a Proton Pump Inhibitor: Results from the TRITON-TIMI 38 Trial. |
|
Sep. 29. 09 |